HB 3972

  • Illinois House Bill
  • 103rd Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Procurement-State Drug Label

Abstract

Amends the Illinois Procurement Code. Provides that the Department of Central Management Services, in consultation with the Chief Procurement Officer, shall implement and develop a program to establish a State prescription generic drug label for the purpose of increasing competition in the generic drug market and lowering generic drug prices for all purchasers. Provides the label shall include a list of the 100 most commonly prescribed drugs. Provides that the Department shall contract with one or more generic drug manufacturers to manufacture certain generic drugs on behalf of the State and participating entities. Provides for the adoption of rules.

Bill Sponsors (5)

Votes


No votes to display

Actions


Mar 10, 2023

House

House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee

House

Rule 19(a) / Re-referred to Rules Committee

Mar 08, 2023

House

House Committee Amendment No. 1 Referred to Prescription Drug Affordability & Accessibility Committee

House

Added Co-Sponsor Rep. Harry Benton

Mar 06, 2023

House

House Committee Amendment No. 1 Referred to Rules Committee

House

House Committee Amendment No. 1 Filed with Clerk by Rep. Robert "Bob" Rita

House

Added Co-Sponsor Rep. Jonathan Carroll

House

Added Co-Sponsor Rep. Barbara Hernandez

Feb 28, 2023

House

Assigned to Prescription Drug Affordability & Accessibility Committee

Feb 22, 2023

House

Added Co-Sponsor Rep. Nabeela Syed

Feb 17, 2023

House

First Reading

House

Filed with the Clerk by Rep. Robert "Bob" Rita

House

Referred to Rules Committee

Bill Text

Bill Text Versions Format
Introduced HTML PDF
House Amendment 001 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.